JenaValve tau xaiv Kari Moore ua Tus Thawj Saib Xyuas Nyiaj Txiag

IRVINE, Calif., Tsib Hlis 17, 2022 (GLOBE NEWSWIRE) - JenaValve Technology, Inc. ("JenaValve lossis "Company"), tus tsim tawm thiab cov chaw tsim khoom ntawm qhov sib txawv ntawm transcatheter aortic valve hloov (TAVR) systems, hnub no tshaj tawm kev teem caij ntawm Kari Moore ua lub tuam txhab Tus Thawj Saib Xyuas Nyiaj Txiag pib txij lub Tsib Hlis 10, 2022. "Peb zoo siab tos txais Kari rau pab pawg JenaValve," said JenaValve CEO John Kilcoyne. kev lag luam kho mob. Kari txoj kev paub dav dav thiab kev paub txog kev lag luam yuav pab peb txuas ntxiv ua peb cov tswv yim kho mob thiab ua ntej peb Trilogy rau kev kho mob aortic valve ® Commercialization Efforts rau Heart Valve Systems. " Ms. Moore koom nrog JenaValve tom qab yav tas los ua Tus Thawj Saib Xyuas Nyiaj Txiag rau Envista Holdings Corporation, lub tuam txhab kho hniav thoob ntiaj teb, uas nws tau ua lub luag haujlwm rau kev suav nyiaj thoob ntiaj teb, nyiaj txiag thiab kev pabcuam sib koom ua haujlwm. Ua ntej koom nrog Envista Holdings Corporation, Ms. Moore yog tus Thawj Coj. Accounting Officer ntawm Applied Medical Corporation, lub tuam txhab kho mob thoob ntiaj teb muab technologies thiab kev daws teeb meem rau minimally invasive thiab general phais.Ms. Moore tau pib nws txoj haujlwm ntawm PricewaterhouseCoopers, qhov chaw uas nws tau ua haujlwm ua tus koom tes tshawb xyuas, tshwj xeeb hauv kev lag luam hauv lub neej.Ntawm nws txoj haujlwm 20 xyoo, Ms. Moore tau coj ntau lub tuam txhab pej xeem thiab pab lawv hauv kev yuav khoom, divestitures thiab nuj nqis.Kari tuav a BA hauv Kev Tswj Lag Luam los ntawm University of Southern California thiab yog CPA hauv xeev California. "Kuv zoo siab tau koom nrog JenaValve thaum lub sijhawm tseem ceeb," Ms. Moore hais. "Kuv zoo siab ua haujlwm nrog tag nrho pab pawg JenaValve thaum peb txuas ntxiv ua haujlwm ntawm peb txoj kev loj hlob thiab muaj txiaj ntsig tsim cov tswv yim thaum txhim kho lub neej ntawm cov neeg mob." Hais txog JenaValve JenaValve Technology, Inc., headquartered nyob rau hauv Irvine, California, nrog rau cov chaw nyob rau hauv Leeds, UK thiab Munich, lub teb chaws Yelemees, tsim thiab manufactures transcatheter aortic valve hloov (TAVR) systems rau kev kho mob ntawm cov neeg mob aortic valve kab mob.JenaValve yog txhawb los ntawm Bain Capital Life Sciences thiab Cormorant Asset Management, nrog rau European thiab Asian cov tub ua lag luam suav nrog Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners thiab Peijia Medical Limited (HKEx: 9996) . Teb Chaws Asmeskas: Saib Xyuas - Cov Khoom Siv Tshawb Fawb. Txwv tsis pub siv los ntawm tsoomfwv (lossis Asmeskas) txoj cai rau kev tshawb fawb siv nkaus xwb.